MovDisordV3, PubMed, Checkpoint, bibRecord, 002025

The variability of levodopa response in Parkinson's disease: is sensitization reversible?

Identifieur interne : 002025 ( PubMed/Checkpoint ); précédent : 002024; suivant : 002026

The variability of levodopa response in Parkinson's disease: is sensitization reversible?

Auteurs : Mazen G. Jabre ; Boulos-Paul W. Bejjani

Source :

Movement disorders : official journal of the Movement Disorder Society [ 1531-8257 ] ; 2008.

RBID : pubmed:18163452

English descriptors

KwdEn :
- Antiparkinson Agents (therapeutic use), Dopamine Agonists (therapeutic use), Dose-Response Relationship, Drug, Humans, Levodopa (therapeutic use), Parkinson Disease (drug therapy), Parkinson Disease (pathology), Pergolide (therapeutic use), Treatment Outcome.
MESH :
- chemical , therapeutic use : Antiparkinson Agents, Dopamine Agonists, Levodopa, Pergolide.
- drug therapy : Parkinson Disease.
- pathology : Parkinson Disease.
- Dose-Response Relationship, Drug, Humans, Treatment Outcome.

DOI: 10.1002/mds.21893
PubMed: 18163452

Affiliations:

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 002370
to stream PubMed, to step Curation: 002370

Links to Exploration step

pubmed:18163452

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The variability of levodopa response in Parkinson's disease: is sensitization reversible?</title>
<author><name sortKey="Jabre, Mazen G" sort="Jabre, Mazen G" uniqKey="Jabre M" first="Mazen G" last="Jabre">Mazen G. Jabre</name>
</author>
<author><name sortKey="Bejjani, Boulos Paul W" sort="Bejjani, Boulos Paul W" uniqKey="Bejjani B" first="Boulos-Paul W" last="Bejjani">Boulos-Paul W. Bejjani</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="doi">10.1002/mds.21893</idno>
<idno type="RBID">pubmed:18163452</idno>
<idno type="pmid">18163452</idno>
<idno type="wicri:Area/PubMed/Corpus">002370</idno>
<idno type="wicri:Area/PubMed/Curation">002370</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002025</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The variability of levodopa response in Parkinson's disease: is sensitization reversible?</title>
<author><name sortKey="Jabre, Mazen G" sort="Jabre, Mazen G" uniqKey="Jabre M" first="Mazen G" last="Jabre">Mazen G. Jabre</name>
</author>
<author><name sortKey="Bejjani, Boulos Paul W" sort="Bejjani, Boulos Paul W" uniqKey="Bejjani B" first="Boulos-Paul W" last="Bejjani">Boulos-Paul W. Bejjani</name>
</author>
</analytic>
<series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antiparkinson Agents (therapeutic use)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Humans</term>
<term>Levodopa (therapeutic use)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (pathology)</term>
<term>Pergolide (therapeutic use)</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Dopamine Agonists</term>
<term>Levodopa</term>
<term>Pergolide</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Dose-Response Relationship, Drug</term>
<term>Humans</term>
<term>Treatment Outcome</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">18163452</PMID>
<DateCreated><Year>2008</Year>
<Month>05</Month>
<Day>01</Day>
</DateCreated>
<DateCompleted><Year>2008</Year>
<Month>08</Month>
<Day>06</Day>
</DateCompleted>
<DateRevised><Year>2013</Year>
<Month>11</Month>
<Day>21</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>23</Volume>
<Issue>6</Issue>
<PubDate><Year>2008</Year>
<Month>Apr</Month>
<Day>30</Day>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>The variability of levodopa response in Parkinson's disease: is sensitization reversible?</ArticleTitle>
<Pagination><MedlinePgn>924; author reply 925</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.21893</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jabre</LastName>
<ForeName>Mazen G</ForeName>
<Initials>MG</Initials>
</Author>
<Author ValidYN="Y"><LastName>Bejjani</LastName>
<ForeName>Boulos-Paul W</ForeName>
<Initials>BP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016420">Comment</PublicationType>
<PublicationType UI="D016422">Letter</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000978">Antiparkinson Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018491">Dopamine Agonists</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>24MJ822NZ9</RegistryNumber>
<NameOfSubstance UI="D010479">Pergolide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>46627O600J</RegistryNumber>
<NameOfSubstance UI="D007980">Levodopa</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Mov Disord. 2007 May 15;22(7):990-7</RefSource>
<PMID Version="1">17443692</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000978">Antiparkinson Agents</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D018491">Dopamine Agonists</DescriptorName>
<QualifierName MajorTopicYN="N" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D004305">Dose-Response Relationship, Drug</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D007980">Levodopa</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000188">drug therapy</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D010479">Pergolide</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2008</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2008</Year>
<Month>8</Month>
<Day>7</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2008</Year>
<Month>1</Month>
<Day>1</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="doi">10.1002/mds.21893</ArticleId>
<ArticleId IdType="pubmed">18163452</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list></list>
<tree><noCountry><name sortKey="Bejjani, Boulos Paul W" sort="Bejjani, Boulos Paul W" uniqKey="Bejjani B" first="Boulos-Paul W" last="Bejjani">Boulos-Paul W. Bejjani</name>
<name sortKey="Jabre, Mazen G" sort="Jabre, Mazen G" uniqKey="Jabre M" first="Mazen G" last="Jabre">Mazen G. Jabre</name>
</noCountry>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002025 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002025 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:18163452
   |texte=   The variability of levodopa response in Parkinson's disease: is sensitization reversible?
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:18163452" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Movement Disorders (revue)

The variability of levodopa response in Parkinson's disease: is sensitization reversible?

The variability of levodopa response in Parkinson's disease: is sensitization reversible?

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki